Suppr超能文献

β-酪啡肽-7 通过靶向 NF-κB 通路减轻脓毒症诱导的急性肾损伤。

β-Casomorphin-7 Ameliorates Sepsis-Induced Acute Kidney Injury by Targeting NF-κB Pathway.

机构信息

Department of Anesthesiology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, China (mainland).

Department of Anesthesiology, Taishan Medical University Affiliated Liaocheng Second People's Hospital, Linqing, Shandong, China (mainland).

出版信息

Med Sci Monit. 2019 Jan 5;25:121-127. doi: 10.12659/MSM.912730.

Abstract

BACKGROUND The aim of this study was to investigate the protective effect of β-casomorphin-7 (β-CM-7) and its possible mechanisms on acute kidney injury (AKI). MATERIAL AND METHODS Rats were randomly divided into a sham group, a cecal ligation and puncture (CLP) group, and a CLP+β-CM-7 group. Kidney index, kidney function, and histopathology changes were assessed. The expression of neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (Kim-1), nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor alpha (IκBα), and p-IκBα in kidney tissues were detected by Western blotting. Inflammatory and oxidative stress factors were detected by ELISA kits. RESULTS The results showed that treatment with β-CM-7 reduced the levels of creatinine (Cre), blood urea nitrogen (BUN), NGAL, and Kim-1 induced by CLP, weakening the pathological damage. In the CLP + β-CM-7 group, the tumor necrosis factor-α (TNF-α) level and the DNA-binding activity of NF-κB p65 were significantly reduced and the interleukin-10 (IL-10) level was significantly increased compared with the CLP group. β-CM-7 decreased the expression of p-IκBα/IκBα. In addition, β-CM-7 increased the activity of superoxide dismutase (SOD) and decreased the level of malondialdehyde (MDA) in kidney tissue. CONCLUSIONS β-CM-7 attenuated sepsis-induced AKI through reducing inflammation and oxidative stress and by inhibition of nuclear factor (NF)‑κB activities. This study provides a new therapeutic agent for attenuating sepsis-induced kidney injury.

摘要

背景

本研究旨在探讨β-酪啡肽-7(β-CM-7)对急性肾损伤(AKI)的保护作用及其可能机制。

材料与方法

将大鼠随机分为假手术组、盲肠结扎穿孔(CLP)组和 CLP+β-CM-7 组。评估肾脏指数、肾功能和组织病理学变化。采用 Western blot 检测肾脏组织中中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、肾损伤分子-1(Kim-1)、核因子κB 轻链增强子B 细胞抑制剂α(IκBα)和 p-IκBα 的表达。采用 ELISA 试剂盒检测炎症和氧化应激因子。

结果

结果表明,β-CM-7 治疗可降低 CLP 诱导的肌酐(Cre)、血尿素氮(BUN)、NGAL 和 Kim-1 水平,减轻病理损伤。在 CLP+β-CM-7 组中,肿瘤坏死因子-α(TNF-α)水平和 NF-κB p65 的 DNA 结合活性明显低于 CLP 组,白细胞介素-10(IL-10)水平明显升高。β-CM-7 降低了 p-IκBα/IκBα 的表达。此外,β-CM-7 增加了肾脏组织中超氧化物歧化酶(SOD)的活性,降低了丙二醛(MDA)的水平。

结论

β-CM-7 通过减轻炎症和氧化应激以及抑制核因子(NF)-κB 活性,减轻脓毒症引起的 AKI。本研究为减轻脓毒症引起的肾脏损伤提供了一种新的治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/473e/6330023/96b3430f18e3/medscimonit-25-121-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验